3571-3580 of 4400 results
Report: An update on our predictions for the year ahead across the private equity market
The first half of 2018 has seen a flurry of public-to-private activity that should continue to keep dealmakers busy for the remainder of the calendar year However the mountain of dry powder competing for limited quality investment opportunities remains an issue that has prompted a diversification in ...
The National Energy Guarantee's Reliability Guarantee and what it means for you
Following the release of the National Energy Guarantee draft design consultation paper by the Energy Security Board Partner Anna Collyer and Associate Mark Leersnyder report on the NEGs proposed Reliability Guarantee component which gives a greater role to regulatory institutions to plan and manage ...
Considering Robo-advice
The Australian Financial Complaints Authority AFCA the new one-stop-shop for resolving financial complaints has had a very busy first six months of operation ...
New Decree on labour outsourcing services
Taking effect from 5 May 2019, a new Decree on labour outsourcing services has been introduced with changes including a relaxation of licence application conditions, and the imposition of further restrictions in relation to the deposit aimed at providing greater protection for contract employees. ...
Compensating superannuation members for 'fees for no advice'
APRA and ASIC issued a joint letter to all RSE licensees entitled 'Oversight of fees charged to members' superannuation accounts' in early April, in response to the 'fee for no advice' issue that attracted so much attention in the Royal Commission ...
Global trade mark update
There have been significant, and proposed, trade mark law developments across the globe which are likely to inform trade mark portfolio strategy. ...
Licence to infringe: Patent Office grants Sandoz licence to exploit Lexapro® patent
In the latest chapter of one the longest-running sagas in Australian patent litigation history, the Deputy Commissioner of Patents has retrospectively granted Sandoz a licence to exploit Lundbeck's patent for its blockbuster antidepressant Lexapro® (escitalopram). The licence, only the second of its kind to be granted in Australia, provides Sandoz with a defence to Lundbeck's multi-million dollar infringement claim. ...
Lag and loss: managing the impacts of delay in project delivery
Three recent UK decisions highlight contractual mechanisms for managing aspects of risks associated with delay in project delivery Projects Partner Leighton OBrien considers the implications for projects in Australasia ...
Report: National Electricity & Gas Rules Update: May 2019
In this update we summarise the progress of new and existing rule change requests across the month of May and take a closer look at the AEMC's final report on the regulatory framework for stand-alone power systems. ...
No relief in PBS price changes for originators seeking injunctions
Patentees may face heightened risks when changes to the Pharmaceutical Benefits Scheme (PBS) take effect later this year. Special Counsel Ric Morgan and Associate Claire Gregg explain. ...